OmniAsset
Get app

OmniAsset › Mutual funds › ITI Pharma and Healthcare Fund

ITI Pharma and Healthcare Fund

Sectoral / Thematic fund benchmarked to Nifty Healthcare Total Return Index. Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 202620.0127
CategorySectoral / Thematic
PlanDirect · Growth
Launched18 Oct 2021
Risk labelthe scheme's own riskometerVery High risk
Legal benchmarkSEBI Tier-1Nifty Healthcare Total Return Index
Expense ratiodirect plan, a year0.92%
AUM₹18.8 Cr
Growth of ₹10,000₹20,00211 Nov 2021 to 2 Sep 2026
₹20,274₹17,338₹14,402₹11,466₹8,530Nov 2021Jan 2023Apr 2024Jun 2025Sep 2026
₹20,002 (+15.5% a year) ITI Pharma and Healthcare Fund

Performance (trailing, annualised)

1Y annualised15.22%
3Y annualised20.90%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,37,37727.79%
SIP 3Y (₹10,000 a month)invested ₹3,60,000 → worth ₹4,55,84115.94%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Calendar years

Calendar 2022-6.68%
Calendar 202334.39%
Calendar 202443.95%
Calendar 2025-8.24%

Rolling returns

Rolling 1Y · average197 windows since 16 Nov 202219.42%
Rolling 1Y · median17.08%
Rolling 1Y · worst window-9.33%
Rolling 1Y · best window58.86%
Rolling 1Y · windows positive78%
Rolling 3Y · average94 windows since 11 Nov 202421.80%
Rolling 3Y · median21.51%
Rolling 3Y · worst window17.57%
Rolling 3Y · best window26.75%
Rolling 3Y · windows positive100%

Every window of that length in the published history, so one lucky start date cannot flatter the fund.

Risk

Volatility (3Y)14.21%
Downside deviation (3Y)10.02%
Maximum drawdown-17.07%

Management

Fund managerMr. Animesh Singh, Mr. Nilay Dalal
Managing since8 May 2026

Related

Source: the OmniAsset signed reference snapshot, as of 4 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker